What is the recommended initial treatment protocol for diabetic ketoacidosis?

Initial Treatment Protocol for Diabetic Ketoacidosis

For moderate-to-severe DKA, initiate aggressive intravenous fluid resuscitation with 0.9% normal saline or crystalloid followed by continuous intravenous insulin infusion (0.1 units/kg/h), with careful potassium monitoring and replacement to prevent life-threatening hypokalaemia. 1

Fluid Resuscitation

• Begin with 0.9% normal saline (or other crystalloid) at a clinically appropriate rate, aiming to replace 50% of the estimated fluid deficit in the first 8-12 hours 1
• Isotonic fluid resuscitation remains the standard initial approach, though balanced crystalloid solutions have demonstrated faster DKA resolution in some studies 2
• For severe hypovolemia, more aggressive initial fluid replacement is warranted; hemodynamic monitoring and pressors may be necessary in cases of cardiac compromise 1

Insulin Therapy

Continuous intravenous insulin infusion is the preferred regimen for moderate-to-severe DKA 1:

• Start with 0.1 units/kg/h of short-acting insulin as a fixed-rate intravenous infusion after establishing adequate renal function 1
• For mild DKA, consider 0.1 units/kg subcutaneous rapid-acting insulin analog every 1 hour or 0.2 units/kg every 2 hours as an alternative 1
• Some protocols recommend a 0.1 units/kg rapid-acting insulin analog subcutaneous bolus at initiation, though there is debate about withholding insulin until glucose stops dropping with fluid administration alone 1
• British guidelines suggest adding subcutaneous insulin glargine alongside continuous IV insulin, which has shown faster DKA resolution and shorter hospital stays 2

Glucose Management During Treatment

• When blood glucose falls to 200 mg/dL, add dextrose-containing fluids (5-10% dextrose) alongside 0.9% NaCl/crystalloid 1
• Target glucose between 150-200 mg/dL for DKA until resolution (200-250 mg/dL for HHS) 1
• Reduce insulin infusion rate from 0.1 to 0.05 units/kg/h when blood glucose drops below 14 mmol/L (252 mg/dL) to reduce hypoglycemia risk, though real-world implementation of this guideline has been suboptimal 3

Potassium Replacement - Critical Priority

Hypokalaemia occurs in approximately 50% of DKA cases during treatment and severe hypokalaemia (<2.5 mEq/L) is associated with increased inpatient mortality 1:

• If K+ is <3.5 mmol/L at presentation, start insulin but do NOT give potassium; check serum K+ every 2 hours 1
• If K+ is 3.5-5.0 mmol/L, give potassium in each liter of IV fluid as needed to maintain serum K+ between 4-5 mmol/L 1
• If K+ is >5.0 mmol/L, establish adequate renal function (urine output >0.5 mL/kg/h) before potassium administration 1
• Systematic monitoring of potassium concentrations is essential throughout treatment 1

Monitoring Requirements

• Check electrolytes, renal function, venous pH, osmolality, and glucose every 2-4 hours until stable 1
• Monitor for cerebral edema, particularly in cases of rapid hyperglycemia overcorrection - a rare but potentially fatal complication 2
• Regular monitoring for hypophosphatemia and hypomagnesemia is also essential 2

Bicarbonate Use - Generally Not Recommended

• Bicarbonate should NOT be routinely administered, as it has shown no benefit in resolution of acidosis or time to discharge and may worsen ketosis and hypokalaemia 1, 4
• Consider bicarbonate only if serum pH falls below 6.9, or when pH <7.2 and/or bicarbonate <10 mEq/L in the peri-intubation period to prevent hemodynamic collapse 2

Resolution Criteria

DKA is considered resolved when 1:

• Blood glucose <200 mg/dL
• Serum bicarbonate ≥18 mmol/L
• Venous pH >7.3
• Anion gap ≤12 mmol/L

Transition to Subcutaneous Insulin

• Continue IV insulin infusion for 2-4 hours AFTER administering subcutaneous basal insulin to prevent rebound hyperglycemia and recurrent ketoacidosis 1
• Estimate total daily subcutaneous insulin dose from the average insulin infused during the 12 hours before transition 1
• Some evidence suggests administering low-dose basal insulin analog alongside IV insulin may prevent rebound hyperglycemia without increasing hypoglycemia risk 1

Common Pitfalls to Avoid

• Never start insulin before ensuring potassium is >3.5 mmol/L - this can precipitate life-threatening cardiac arrhythmias 1
• Avoid rapid overcorrection of hyperglycemia, which increases cerebral edema risk 2
• Do not stop IV insulin before subcutaneous basal insulin has adequate time to take effect (2-4 hours) 1
• SGLT2 inhibitors should be discontinued 3-4 days before elective surgery to prevent euglycemic DKA 1, 5